Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phreesia (PHR)
:PHR
Holding PHR?
Track your performance easily
PHR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$17.07 - $29.16
Previous CloseN/A
Volume173.69K
Average Volume (3M)437.31K
Market Cap
$1.56B
Enterprise Value$998.12M
Total Cash (Recent Filing)$10.50M
Total Debt (Recent Filing)$20.11M
Price to Earnings (P/E)―
Beta2.49
Next Earnings
Mar 26, 2025EPS Estimate
-0.18Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.47
Shares Outstanding58,124,080
10 Day Avg. Volume393,921
30 Day Avg. Volume437,307
Standard Deviation0.17
R-Squared0.09
Alpha0.00207
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.84
Price to Cash Flow (P/CF)67.30
P/FCF Ratio242.90
Enterprise Value/Market Cap0.64
Enterprise Value/Revenue2.46
Enterprise Value/Gross Profit4.30
Enterprise Value/Ebitda-19.73
Forecast
1Y Price Target
$31.40Price Target Upside17.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
Phreesia News
PremiumCompany Announcements
Phreesia’s Global Expansion: Navigating Legal Hurdles and Compliance Costs
PremiumCompany Announcements
Phreesia Reports Strong Q3 2025 PerformanceBulls Say, Bears Say
Bulls Say
Financial PerformanceUpward revisions to adjusted EBITDA and positive free cash flow generation are encouraging signs for Phreesia.
Market PositionPhreesia has a strong market position, facilitating more than 150 million visits, or over 10% of patient visits in the U.S., with over 100 pharmaceutical brands including all of the top 10 global pharmaceutical companies as customers.
Product DevelopmentPhreesia's new pharmacy-related product aims to drive greater medication adherence, complementing existing offerings and boosting revenue growth opportunities.
Bears Say
Financial GuidanceRevenue guidance for FY'25 and FY'26 has been reduced, with estimates below previous projections.
Investment ReturnsRecent investments, such as the Patient Activation Measure (PAM) or Phreesia OnCall service, do not deliver ROI.
Revenue GrowthPhreesia's revenue growth is moderating, with the subscription growth and FY'25 revenue guidance being below estimates.
---
Ownership Overview
6.25% Insiders
38.80% Mutual Funds
0.28% Other Institutional Investors
41.73% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PHR FAQ
What was Phreesia’s price range in the past 12 months?
Phreesia lowest stock price was $17.07 and its highest was $29.16 in the past 12 months.
What is Phreesia’s market cap?
Phreesia’s market cap is $1.56B.
When is Phreesia’s upcoming earnings report date?
Phreesia’s upcoming earnings report date is Mar 26, 2025 which is in 67 days.
How were Phreesia’s earnings last quarter?
Phreesia released its earnings results on Dec 09, 2024. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.237 by -$0.013.
Is Phreesia overvalued?
According to Wall Street analysts Phreesia’s price is currently Undervalued.
Does Phreesia pay dividends?
Phreesia does not currently pay dividends.
What is Phreesia’s EPS estimate?
Phreesia’s EPS estimate is -0.18.
How many shares outstanding does Phreesia have?
Phreesia has 58,124,080 shares outstanding.
What happened to Phreesia’s price movement after its last earnings report?
Phreesia reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.237. Following the earnings report the stock price went up 11.604%.
Which hedge fund is a major shareholder of Phreesia?
Among the largest hedge funds holding Phreesia’s share is Deerfield Management Company, LP. It holds Phreesia’s shares valued at 12M.
---
Phreesia Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$31.40 (17.16% Upside)
$31.40 (17.16% Upside)
Blogger Sentiment
Bullish
PHR Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 212.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $750.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 7.2%
Last 30 Days ▲ 15.8%
Last 30 Days ▲ 15.8%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.23%
12-Months-Change
Fundamentals
Return on Equity
-31.89%
Trailing 12-Months
Asset Growth
0.28%
Trailing 12-Months
Company Description
Phreesia
Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.
---
PHR Company Deck
---
PHR Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance with notable revenue growth and profitability improvements. The company demonstrated positive cash flow metrics and provided a promising outlook for fiscal 2026. Despite minor setbacks from a client wind-down and a slightly adjusted revenue outlook for fiscal 2025, the overall sentiment was positive, driven by strong operational performance and strategic growth plans.Read More>---
PHR Revenue Breakdown
45.91% Subscription and related services
27.90% Payment processing fees
26.19% Network solutions
---
PHR Stock 12 Month Forecast
Average Price Target
$31.40
▲(17.16% Upside)
Technical Analysis
Best Analysts Covering PHR
1 Year
1 Year Success Rate
7/12 ratings generated profit
1 Year Average Return
-4.20%
reiterated a buy rating last month
Copying Anne Samuel's trades and holding each position for 1 Year would result in 58.33% of your transactions generating a profit, with an average return of -4.20% per trade.
---